AXTI Q3 Earnings Beat on Record InP Sales and Margin Gains

AXT reported Q3 2026 non-GAAP EPS of $0.41 versus $0.31 expected and revenue up 162% year over year to $73.4 million, 11.05% above consensus. Record InP revenue was $54.3 million, non-GAAP gross margin expanded to 56.1% from 22.4% a year earlier, and backlog exceeded $500 million. Management projects Q4 revenue of about $90 million, non-GAAP EPS of $0.57–$0.59 and gross margin potentially above 60%; InP supply remains constrained, and AXT received a $43.5 million wafer prepayment from Lumentum.

Analysis

The key market question is whether AXTI can convert temporary scarcity into durable pricing power before its own capacity and peers’ output catch up. Allocation and long lead times give it near-term leverage, but the planned capacity ramp makes today’s exceptional margins vulnerable: if demand growth slows or 4-/6-inch qualification is delayed, new fixed costs could arrive before saleable volume. The 2027 supply response is therefore as important as the current demand signal.

Lumentum (LITE) is a clear customer-side beneficiary of securing wafer supply, though its prepayment also creates exposure to AXTI’s delivery and qualification execution. The advance is a financing liability until shipment, not proof of realized downstream revenue. AXTI’s customer concentration and China-linked expansion add asymmetric risks: a delayed large-customer program, export-policy change, or incomplete Tongmei funding/listing could disrupt the growth path or alter the economics of the subsidiary.

Near term, the setup favors estimate revisions if Q4 shipments and margin guidance are delivered. Over 1–3 months, verify recognized revenue versus backlog/prepayments, wafer yields, and customer qualification. Over 6–18 months, monitor whether planned capacity growth outruns optical-interconnect demand and compresses wafer pricing. The consensus may be underweighting the eventual supply-cycle reversal, even while underestimating near-term earnings torque. No valuation or current-price data are supplied, so avoid an unconditional chase.

Key Decisions for Investors

• AXTI: Prefer a staged long on post-earnings weakness rather than buying a gap higher; the near-term catalyst is conversion of the Q4 outlook into shipped, recognized revenue. Reassess if reported revenue materially misses the company’s outlook or gross margin fails to approach its stated >60% potential.
• Use a defined-risk bullish call spread only if options pricing and liquidity are attractive; cap exposure because the upside case depends on execution and the stock’s valuation is not provided. Avoid naked short-volatility positions around the next results update.
• Track AXTI’s backlog quality: separate firm, shippable orders from cancellable/conditional orders, and distinguish prepayments from revenue. A falling backlog alongside rising capacity, or evidence of weaker wafer pricing, would falsify the scarcity thesis and argue for reducing or reversing the long.
• Monitor LITE delivery/qualification commentary and AXTI’s customer concentration, export-permit status, Tongmei financing subscription, and 2027 capacity utilization. Treat disruption or delayed qualification as a downside alert; the current information does not support a standalone LITE trade.